Presented By: Jahan Marcu, PhD
Speaker Biography: Dr. Jahan Marcu has over 15 years of experience in cannabis research, policy, and operations. He has been a passionate advocate focused on consumer safety and the medical benefits of cannabis. He is also among a select group of professionals globally that has earned a PhD focused on the endocannabinoid system (with research on the structure and function of cannabinoid receptors, molecular pharmacology of the endocannabinoid system). Furthermore, his efforts include the development of international certification and training programs, co-authoring American Herbal Pharmacopeia’s Cannabis Quality Control and Therapeutic Monographs. And he is credited for assisting in the creation of the first nationally adopted standards for the cannabis and hemp industry as the laboratory committee chairman of the cannabis committee for the American Herbal Products Association (AHPA). His dedication to consumer safety is further evident in his work to co-develop a biotech application to predict drug-drug interactions between cannabis and commonly prescribed pharmaceutical drugs. Additionally, Dr. Marcu co-authored one of the first product safety studies on CBD products. Dr. Marcu also provides advising services to government offices in the United States…
Webinar: Debunking Myths and Misconceptions of the Psychedelics Industry
Webinar Abstract: As another psychedelic renaissance begins to take flight, it seems that myths and misconceptions rise to meet it. As a molecular pharmacologist studying cannabinoids and psychedelics with training in psilocybin-assisted therapy, I believe it’s vital to dispel these misconceptions. Whether you are a consumer, an investor or simply interested in navigating the chaos that surrounds this burgeoning industry, below are a few mind munchies (aka food for thought) intended to provide some accessible guidance and insight. The topics discussed in this webinar will be regarding the pharmacological history of psychedelics, the varieties of sources of psychedelics, the mechanisms of action of psilocybin and LSD, publicly traded companies in this space, and misconceptions about some of the health outcomes attributed to psychedelics.
Learning Objectives:
1. Summarize the mechanisms of action of psychedelics such as psilocybin and LSD.
2. Discuss the various sources of psychedelics substances, and related environmental issues associated with certain sources.
Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots https://www.labroots.com/webinar/debunking-myths-misconceptions-psychedelics-industry
2. Watch the webinar on YouTube or on the LabRoots Website https://www.labroots.com/ms/webinar/debunking-myths-misconceptions-psychedelics-industry
3. Click Here to get your PACE credits (Expiration date – March 10, 2024): https://www.labroots.com/credit/pace-credits/7090/third-party
LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc
source
